Abstract:The effects on locomotor response to cocaine challenge, acquisition of cocaine conditioned place preference and cocaine-induced dopamine (DA) release in nucleus accumbens and ventral tegmental area by the non-specific corticotropin-releasing factor (CRF) receptors antagonist alpha-helical CRF, the selective CRF receptor subtype 1 antagonist CP-154,526 and the selective CRF receptor subtype 2 antagonist anti-sauvagine-30 (AS-30) were investigated in rats. Both alpha-helical CRF (10 mug, i.c.v.) and CP-154,526 (3 mug, i.c.v.) decreased the cocaine-induced distance travelled, whereas AS-30 (3 mug, i.c.v.) did not show such an effect. The CRF receptor antagonists also have significant effects on stereotype counts induced by cocaine injection, in which the alpha-helical CRF or CP-154,526 but not AS-30 did significantly reduce the stereotype counts. alpha-Helical CRF (10 mug) prior to each injection of cocaine blocked cocaine conditioned place preference with no significant difference observed in the time spent in the drug-paired side between post- and pre-training and both 1 and 3 mug CP-154,526 also had significant inhibitory effects on cocaine-induced place preference. However, pre-treatment with an i.c.v. infusion of AS-30 (1 or 3 mug) prior to each injection of cocaine did not affect the acquisition of conditioned place preference. The alpha-helical CRF and CP-154,526 reduced extracellular DA levels of nucleus accumbens and ventral tegmental area in response to the injection of cocaine. However, both alpha-helical CRF and CP-154,526 did not modify extracellular DA levels under basal conditions. In contrast, the i.c.v. infusion of AS-30 had no effects on either the basal DA or the cocaine-induced increase in DA release in nucleus accumbens and ventral tegmental area. These findings demonstrate that activation of the CRF receptor is involved in behavioral and neurochemical effects of cocaine challenge and cocaine reward and that the role of CRF receptor subtypes 1 and 2 in cocaine-induced locomotion, reward and DA release is not identical. The CRF receptor subtype 1 is largely responsible for the action of the CRF system on cocaine locomotion and reward. These results suggest that the CRF receptor antagonist, particularly the CRF receptor subtype 1 antagonist, might be of some value in the treatment of cocaine addiction and cocaine-related behavioral disorders.

Elevated Expression of Serotonin 5-HT(2A) Receptors in the Rat Ventral Tegmental Area Enhances Vulnerability to the Behavioral Effects of Cocaine

Cocaine-Induced Chromatin Modifications Associate with Increased Expression and Three-Dimensional Looping of Auts2.

Prominent Activation of Brainstem and Pallidal Afferents of the Ventral Tegmental Area by Cocaine

Cocaine Exposure Enhances the Activity of Ventral Tegmental Area Dopamine Neurons Via Calcium-Impermeable NMDARs.

Increased cocaine self-administration in rats lacking the serotonin transporter: a role for glutamatergic signaling in the habenula

Ultrahigh-resolution MRI Reveals Structural Brain Differences in Serotonin Transporter Knockout Rats after Sucrose and Cocaine Self-Administration

Activation of RMTg projections to the VTA reverse cocaine-induced molecular adaptation in the reward system

Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist

Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats

Cocaine induces locomotor sensitization through a dopamine-dependent VTA-mPFC-FrA cortico-cortical pathway in male mice

Activation of nucleus accumbens projections to the ventral tegmental area alters molecular signaling and neurotransmission in the reward system

Cocaine Modulation of Frontostriatal Expression of Zif268, D2, and 5-Ht2c Receptors in High and Low Impulsive Rats

Extracellular Dopamine in the Rat Ventral Tegmental Area and Nucleus Accumbens Following Ventral Tegmental Infusion of Cocaine

Cocaine, via ΔFosB, remodels gene expression and excitability in ventral hippocampus

Repeated in Vivo Exposure of Cocaine Induces Long-Lasting Synaptic Plasticity in Hypocretin/orexin-Producing Neurons in the Lateral Hypothalamus in Mice.

5-HT1A Autoreceptor in Dorsal Raphe Nucleus Mediates Sensitization of Conditioned Place Preference to Cocaine in Mice Experienced with Chronic Pain.

VTA glutamatergic projections to the nucleus accumbens suppress psychostimulant-seeking behavior

Ventral tegmental area astrocytes modulate cocaine reward by tonically releasing GABA

Dopamine-Dependent Responses To Cocaine Depend On Corticotropin-Releasing Factor Receptor Subtypes

Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse

β2* nAChR sensitivity modulates acquisition of cocaine self-administration in male rats